Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice
- PMID: 10343058
- DOI: 10.1006/mpat.1999.0273
Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice
Abstract
Salmonella typhimurium rpoS and rpoS aroA mutants are effective live vaccines in the murine model of salmonellosis (Coynault et al., Mol. Microbiol. 1996; 22: 149-60). Here, we further investigate the characteristics of these vaccines. The systemic humoral response induced by S. typhimurium rpoS, aroA and rpoS aroA vaccine candidates against S. typhimurium LPS was studied by ELISA. In BALB/c mice, the rpoS aroA strain induced a systemic anti-LPS humoral response similar to that induced by the rpoS and aroA strains. The virulence of aroA and rpoS aroA vaccines in nude (nu/nu) BALB/c mice was also compared. Salmonella typhimurium aroA and rpoS aroA vaccines both produced slowly progressing lethal infections in athymic mice inoculated i.p. but the rpoS aroA strain was more attenuated than the aroA strain, as determined by time to death and bacterial counts in spleens. Finally, a rpoS mutant of Salmonella dublin conferred protection in mice against an oral challenge with a wild-type strain of S. dublin whereas a rpoS mutant of S. typhimurium did not. This suggests that the protection provided by the S. typhimurium rpoS vaccine is serotype-dependent.
Copyright 1999 Academic Press.
Similar articles
-
The potential Salmonella aroA- vaccine strain is safe and effective in young BALB/c mice.Neonatology. 2007;91(2):114-20. doi: 10.1159/000097128. Epub 2006 Nov 20. Neonatology. 2007. PMID: 17344661
-
Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon.Mol Microbiol. 1996 Oct;22(1):149-60. doi: 10.1111/j.1365-2958.1996.tb02664.x. Mol Microbiol. 1996. PMID: 8899717
-
Genetic detoxification of an aroA Salmonella enterica serovar Typhimurium vaccine strain does not compromise protection against virulent Salmonella and enhances the immune responses towards a protective malarial antigen.FEMS Immunol Med Microbiol. 2008 Mar;52(2):237-46. doi: 10.1111/j.1574-695X.2007.00368.x. Epub 2008 Jan 3. FEMS Immunol Med Microbiol. 2008. PMID: 18177343
-
The use of live attenuated Salmonella for oral vaccination.Dev Biol Stand. 1994;82:35-42. Dev Biol Stand. 1994. PMID: 7958481 Review.
-
Modulation of antigen display by attenuated Salmonella typhimurium strains and its impact on protective immunity against listeriosis.Behring Inst Mitt. 1997 Feb;(98):160-71. Behring Inst Mitt. 1997. PMID: 9382737 Review. No abstract available.
Cited by
-
Problems posed by natural environments for monitoring microorganisms.Mol Biotechnol. 2000 Jul;15(3):211-23. doi: 10.1385/MB:15:3:211. Mol Biotechnol. 2000. PMID: 10986697 Review.
-
Live attenuated vaccines for invasive Salmonella infections.Vaccine. 2015 Jun 19;33 Suppl 3(0 3):C36-41. doi: 10.1016/j.vaccine.2015.04.029. Epub 2015 Apr 19. Vaccine. 2015. PMID: 25902362 Free PMC article. Review.
-
Identification of RpoS (sigma(S))-regulated genes in Salmonella enterica serovar typhimurium.J Bacteriol. 2000 Oct;182(20):5749-56. doi: 10.1128/JB.182.20.5749-5756.2000. J Bacteriol. 2000. PMID: 11004173 Free PMC article.
-
Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.PLoS One. 2010 Jun 18;5(6):e11142. doi: 10.1371/journal.pone.0011142. PLoS One. 2010. PMID: 20585446 Free PMC article.
-
Regulation of Vi capsular polysaccharide synthesis in Salmonella enterica serotype Typhi.J Infect Dev Ctries. 2008 Dec 1;2(6):412-20. doi: 10.3855/jidc.154. J Infect Dev Ctries. 2008. PMID: 19745516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials